Categories: News

Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity

HYDERABAD, India, August 1, 2025 /PRNewswire/ — Zenara Pharma Private Limited (“Zenara”), a Biophore company, today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Capsules, 150 mg and 200 mg. This approval marks the first FDA-approved generic equivalent of the reference listed drug marketed by Almatica Pharma, LLC.

- Advertisement -

The product has also been granted Competitive Generic Therapy (CGT) designation by the FDA. As the first approved applicant under this pathway, Zenara’s ANDA has secured 180 days of marketing exclusivity in the U.S., which commenced with the product’s launch1.

- Advertisement -

Sertraline Hydrochloride Capsules are classified as selective serotonin reuptake inhibitors (SSRIs) and are indicated for the treatment of Major Depressive Disorder (MDD) in adults and Obsessive-Compulsive Disorder (OCD) in adults and pediatric patients aged six years and older.

Commenting on the milestone, Dr. Srinivas Arutla, CEO of Zenara Pharma Pvt. Ltd., said:

- Advertisement -

“Receiving the first generic approval for Sertraline Hydrochloride Capsules highlights Zenara’s strong R&D capabilities and operational excellence. We remain committed to our mission of delivering to patients, early access to high-quality, affordable pharmaceuticals.”

- Advertisement -

According to IQVIA™ sales data for the 12-month period ending June 2025, U.S. sales of the reference product totaled approximately $35.5 million.

About Zenara: 
Zenara Pharma Private Limited – a Biophore company, is a vertically integrated pharmaceutical company, committed to delivering high-quality pharmaceuticals that are safe, effective, and affordable to patients. Zenara is an industry leader in Research and Development and Manufacturing of Affordable and Quality finished dosage pharmaceutical Products. Zenara is focused on the therapeutic areas of Neurology, Orphan Drugs, Complex Products, Women’s health, Cardiology, Imaging, and Contrast Agents among others. For more information, please visit us on the web, or connect with us on our LinkedIn page.
*All brand names and trademarks are the property of their respective owners

- Advertisement -

1 U.S. FDA, Competitive Generic Therapy Approvals

- Advertisement -

Logo- https://mma.prnewswire.com/media/2742318/Zenara_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/zenara-pharma-receives-us-fda-approval–for-first-generic-of-sertraline-hydrochloride-capsules-with-180-day-cgt-exclusivity-302519326.html

- Advertisement -
PRNW Agency

Recent Posts

Aarvee Denims Embarks on a New Era of Quality Growth: Shareholder-Endorsed Transformation Builds on Debt-Free Foundation with Strategic New Leadership & Company Re-name

AHMEDABAD, India, Aug. 22, 2025 /PRNewswire/ -- AARVEE Denims and Exports Limited (NSE: AARVEEDEN) (BSE:…

17 minutes ago

CGTN AMERICA & CCTV UN: EXPLORING THE FUTURE OF STORYTELLING WITH AI

WASHINGTON, Aug. 22, 2025 /PRNewswire/ -- CGTN America & CCTV UN releases "Explore the Future…

18 minutes ago

Bybit Unveils Advanced Multi-Chart Experience in Collaboration with TradingView, Deepens Partnership as Official WSOT 2025 Partner

DUBAI, UAE, Aug. 22, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, …

18 minutes ago

Clean Energy for All: BLUETTI and UN-Habitat Strengthen Partnership to Expand Access to Clean Energy in Africa

NAIROBI, Kenya, Aug. 22, 2025 /PRNewswire/ -- Global clean energy leader BLUETTI has deepened its partnership…

1 hour ago

Abu Dhabi to Host Inaugural Autonomous Week to Showcase the Future of Smart Mobility

Six-day event, organised by the Smart and Autonomous Systems Council (SASC), will showcase latest innovations in smart…

1 hour ago

NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

5 hours ago